Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Syncom Formulations (India) Ltd. Board/Management Information 2024

Aug 12, 2024

60987_rns_2024-08-12_7e075ccb-539a-4fab-883b-cab8505edc5d.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [452 x 73] intentionally omitted <==

SYNCOM/SE/2024-25 12[th] August, 2024 Online filing at: www.listing.bseindia.com and https://neaps.nseindia.com/NEWLISTINGCORP/login.jsp

To, To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Tower, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai (M.H.) 400 001 Mumbai- 400051 BSE CODE:524470 NSE SYMBOL: SYNCOMF

Sub: Disclosure under regulation 30(2) read with Clause 7 of Para A of Part A of Schedule III of the SEBI(LODR) Regulation, 2015: Change in Directorate

Dear Sir,

Pursuant to the Regulation 30 of the SEBI(LODR) Regulation, 2015 read with SEBI Circular No. SEBI/HO/CFD/CFDPoD-1/P/CIR/2023/123 dated 13[th] July 2023, we are hereby submitting disclosures for re-appointment of the following:

  1. Shri Kedarmal Shankarlal Bankda (DIN: 00023050), Chairman and Wholetime Director reappointed w.e.f. 2[nd] May, 2025 for further tenure of two (2) years as a Chairman and Wholetime Director in the category Executive Director of the company.

  2. Shri Vijay Shankarlal Bankda (DIN:00023027) Managing Director of the Company reappointed w.e.f. 29[th] November, 2024 for further tenure of two (2) years as a Managing Director in the category of Executive Director of the company.

We submit the following information as required under the SEBI Listing Regulations read with the SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/2023/120 dated July 11, 2023 as under Anexure-1 and Annexure-2.

We are also in the process to file the aforesaid disclosure in XBRL format within the stipulated time.

We shall make necessary updates in the Management Details Tab as available on the Listing Portal of the BSE and NSE. We shall also disseminate this change on the Company’s website www.sfil.in in due course.

You are requested to kindly take the same on record for your further needful. Thanking You Yours Faithfully,

For, SYNCOM FORMULATIONS (INDIA) LIMITED

Digitally signed by VAISHALI VAISHALI AGRAWAL AGRAWAL Date: 2024.08.12 17:26:00 +05'30'

VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

Encl.: Disclosures as above.

==> picture [452 x 73] intentionally omitted <==

Annexure -1

==> picture [452 x 73] intentionally omitted <==

DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH
SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD-1/P/CIR/2023/123 DATED 13TH JULY 2023
DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH
SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD-1/P/CIR/2023/123 DATED 13TH JULY 2023
DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH
SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD-1/P/CIR/2023/123 DATED 13TH JULY 2023
DISCLOSURES UNDER REGULATION 30 OF THE SEBI(LODR)REGULATION, 2015 READ WITH
SEBI CIRCULAR NO. SEBI/HO/CFD/CFDPOD-1/P/CIR/2023/123 DATED 13TH JULY 2023
1. Re-appointment of Shri Kedarmal Shankarlal Bankda (DIN: 00023050) w.e.f. 2nd May, 2025 as a
Chairman and Wholetime Director under the category of Executive Director:
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re-appointed w.e.f. 2ndMay,2025 on completion of tenure.
b Date
of
~~appointment~~/re-appointment
/~~cessation~~(as applicable) & term of
appointment/re-appointment
2ndMay, 2025 for further tenure of two (2) years
c Profile (in case of appointment);
Shri Kedarmal Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 48 years all around working
experience and looking into all the manufacturing and
administrative functions of the Corporate Office of the
company at Indore and Plant at Pithampur. It would be in the
interest of the Company to continue the employment of Shri
Kedarmal Shankarlal Bankda as Chairman & Whole-Time
Director of theCompany
d Disclosure
of
relationships
between
directors (in case of appointment of a
director).
He is brother of Shri Vijay Shankarlal Bankda, Managing
Director, Father in law of Mrs. Rinki Ankit Bankda, WTD
and father of Shri Ankit Kedarmal Bankda, CFO.
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re-appointed w.e.f. 2ndMay,2025 on completion of tenure.
b Date
of
~~appointment~~/re-appointment
/~~cessation~~(as applicable) & term of
appointment/re-appointment
2ndMay, 2025 for further tenure of two (2) years
c Profile (in case of appointment); Shri Kedarmal Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 48 years all around working
experience and looking into all the manufacturing and
administrative functions of the Corporate Office of the
company at Indore and Plant at Pithampur. It would be in the
interest of the Company to continue the employment of Shri
Kedarmal Shankarlal Bankda as Chairman & Whole-Time
Director of theCompany
d Disclosure
of
relationships
between
directors (in case of appointment of a
director).
He is brother of Shri Vijay Shankarlal Bankda, Managing
Director, Father in law of Mrs. Rinki Ankit Bankda, WTD
and father of Shri Ankit Kedarmal Bankda, CFO.

Brief Profile of Shri Kedarmal Shankarlal Bankda

Shri Kedarmal Shankarlal Bankda is a Post Graduate in commerce and is the core promoter of the company since incorporation and having 48 years all around working experience ,Expert knowledge of accounting standards, Data Analytics, Cost Benefit Analysis.

He is looking into all the manufacturing and administrative functions of the Corporate Office of the company at Indore and Plant at Pithampur.

His bottom up approach way of management is an added advantage which enhances his accuracy in complete plant operations.

It would be in the interest of the Company to continue the employment of Shri Kedarmal Shankarlal Bankda as Chairman & Whole-Time Director of the Company.

Annexure -2
2.Re-appointment of Shri Vijay Shankarlal Bankda (DIN: 00023027) w.e.f. 29th November, 2024 as a
Managing Director under the category of Executive Director:
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re appointed w.e.f, 29thNovember,2024 on completion of
tenure.
b Date
of
~~appointment/~~re-appointment/
~~cessation~~(as applicable) & term of
~~appointment~~/re-appointment
29thNovember, 2024 for further tenure of two (2) years
c Profile (in case of appointment);
Shri Vijay Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 46 years of experience in the
pharmaceutical filed in various capacitates and also
attending commercial operations of the Company, his
experience, commitment and capabilities are playing crucial
role in thegrowth of theCompany. Itwould be in the interest
Annexure -2
2.Re-appointment of Shri Vijay Shankarlal Bankda (DIN: 00023027) w.e.f. 29th November, 2024 as a
Managing Director under the category of Executive Director:
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re appointed w.e.f, 29thNovember,2024 on completion of
tenure.
b Date
of
~~appointment/~~re-appointment/
~~cessation~~(as applicable) & term of
~~appointment~~/re-appointment
29thNovember, 2024 for further tenure of two (2) years
c Profile (in case of appointment);
Shri Vijay Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 46 years of experience in the
pharmaceutical filed in various capacitates and also
attending commercial operations of the Company, his
experience, commitment and capabilities are playing crucial
role in thegrowth of theCompany. Itwould be in the interest
Annexure -2
2.Re-appointment of Shri Vijay Shankarlal Bankda (DIN: 00023027) w.e.f. 29th November, 2024 as a
Managing Director under the category of Executive Director:
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re appointed w.e.f, 29thNovember,2024 on completion of
tenure.
b Date
of
~~appointment/~~re-appointment/
~~cessation~~(as applicable) & term of
~~appointment~~/re-appointment
29thNovember, 2024 for further tenure of two (2) years
c Profile (in case of appointment);
Shri Vijay Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 46 years of experience in the
pharmaceutical filed in various capacitates and also
attending commercial operations of the Company, his
experience, commitment and capabilities are playing crucial
role in thegrowth of theCompany. Itwould be in the interest
Annexure -2
2.Re-appointment of Shri Vijay Shankarlal Bankda (DIN: 00023027) w.e.f. 29th November, 2024 as a
Managing Director under the category of Executive Director:
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re appointed w.e.f, 29thNovember,2024 on completion of
tenure.
b Date
of
~~appointment/~~re-appointment/
~~cessation~~(as applicable) & term of
~~appointment~~/re-appointment
29thNovember, 2024 for further tenure of two (2) years
c Profile (in case of appointment);
Shri Vijay Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 46 years of experience in the
pharmaceutical filed in various capacitates and also
attending commercial operations of the Company, his
experience, commitment and capabilities are playing crucial
role in thegrowth of theCompany. Itwould be in the interest
a Reason for change viz.~~appointment~~, re-
appointment,~~resignation, removal, death~~
~~or otherwise~~; (tenure completion)
Re appointed w.e.f, 29thNovember,2024 on completion of
tenure.
b Date
of
~~appointment/~~re-appointment/
~~cessation~~(as applicable) & term of
~~appointment~~/re-appointment
29thNovember, 2024 for further tenure of two (2) years
c Profile (in case of appointment); Shri Vijay Shankarlal Bankda is a Post Graduate in
commerce and is the core promoter of the company since
incorporation and having 46 years of experience in the
pharmaceutical filed in various capacitates and also
attending commercial operations of the Company, his
experience, commitment and capabilities are playing crucial
role in thegrowth of theCompany. Itwould be in the interest

==> picture [452 x 73] intentionally omitted <==

==> picture [452 x 73] intentionally omitted <==

of the Company to continue the employment of Shri Vijay
Shankarlal Bankda as ManagingDirector of theCompany
d Disclosure
of
relationships
between
directors (in case of appointment of a
director).
He is brother of Shri Kedarmal Shankarlal Bankda, WTD
Managing Director, and relative of Mrs. Rinki Ankit Bankda,
WTD and Shri Ankit Kedarmal Bankda,CFO.

Brief Profile of Shri Vijay Shankarlal Bankda

Shri Vijay Shankarlal Bankda is a Post Graduate in commerce and is the core promoter of the company since incorporation and having 46 years of experience in the pharmaceutical filed in various capacitates.

He also attending commercial operations of the Company, his experience, Knowledge, commitment and capabilities are playing crucial role in the growth of the Company.

The re-appointment would be in the interest of the Company and fruitful for the management to continue the employment of Shri Vijay Shankarlal Bankda as Managing Director of the Company.

For, SYNCOM FORMULATIONS (INDIA) LIMITED

Digitally signed by VAISHALI VAISHALI AGRAWAL AGRAWAL Date: 2024.08.12 17:26:22 +05'30' VAISHALI AGRAWAL COMPANY SECRETARY & COMPLIANCE OFFICER

==> picture [452 x 73] intentionally omitted <==